Response
- PMID: 28709387
- PMCID: PMC6010305
- DOI: 10.1177/1740774517722127
Response
Comment on
-
Commentary on Grady et al.: Using poor, uninsured minorities to test the safety of experimental drugs.Clin Trials. 2017 Oct;14(5):547-550. doi: 10.1177/1740774517722126. Epub 2017 Jul 27. Clin Trials. 2017. PMID: 28747074 No abstract available.
-
Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research.Clin Trials. 2017 Oct;14(5):526-536. doi: 10.1177/1740774517722130. Epub 2017 Aug 8. Clin Trials. 2017. PMID: 28783972 Free PMC article.
References
-
- Elliot C, Abadie R. Exploiting a research underclass in phase 1 clinical trials. N Engl J Med. 2008;358:2316–2317. - PubMed
-
- Abadie R. The professional guinea pig: big pharma and the risky world of human subjects. Durham, NC: Duke University Press; 2010.
-
- Wertheimer A. Exploitation in clinical research. In: Emanuel EJ, Grady CC, Crouch RA, et al., editors. Oxford textbook of clinical research ethics. New York: Oxford U Press; 2008. pp. 201–210.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
